IN-VITRO ACTIVITY OF THE NEW QUINOLONE BAY-Y-3118 AGAINST ANAEROBIC-BACTERIA

被引：13

作者：

NORD, CE ^{[1
]}

LINDMARK, A ^{[1
]}

PERSSON, I ^{[1
]}

机构：

[1] NATL BACTERIOL LAB,S-10521 STOCKHOLM,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1993年 / 12卷 / 08期

关键词：

D O I：

10.1007/BF01973648

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The in vitro activity of BAY y 3118 against anaerobic cocci, Propionibacterium acnes, Clostridium perfringens, Clostridium difficile, Bacteroides fragilis, other Bacteroides spp. and fusobacteria was determined by an agar dilution method. This activity was compared with that of ciprofloxacin, ofloxacin, piperacillin, cefoxitin, imipenem, clindamycin and metronidazole. BAY y 3118, imipenem, clindamycin and metronidazole were the most active agents tested. The in vitro activity of BAY y 3118 against anaerobic bacteria was superior to that of ciprofloxacin and ofloxacin.

引用

页码：640 / 642

页数：3